Elevated urinary NT-proBNP after pharmacological closure of patent ductus arteriosus in very low birth weight infants

Celik I. H., ERDEVE Ö., Demirel G., Canpolat F. E., Dilmen U.

EARLY HUMAN DEVELOPMENT, vol.89, no.3, pp.187-189, 2013 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 89 Issue: 3
  • Publication Date: 2013
  • Doi Number: 10.1016/j.earlhumdev.2012.09.020
  • Journal Name: EARLY HUMAN DEVELOPMENT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.187-189
  • Keywords: Urinary NT-proBNP, Patent ductus arteriosus, Preterm infant, Urinary NT-proBNP/creatinine ratio, BRAIN NATRIURETIC PEPTIDE, HEART-FAILURE
  • Ankara University Affiliated: Yes

Abstract

Background: Hemodynamically significant patent ductus arteriosus (hsPDA) complicates the clinical course of preterm infants and contributes to increased morbidity and mortality. NT-proBNP is indicative of the effects of hsPDA on clinical and cardiac status of patients.